News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,571 Results
Type
Article (8030)
Company Profile (142)
Press Release (479399)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166808)
Career Advice (305)
Deals (25743)
Drug Delivery (7)
Drug Development (52880)
Employer Resources (14)
FDA (9763)
Job Trends (8577)
News (238283)
Policy (17919)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (496)
Accelerated approval (28)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33172)
ALS (116)
Alzheimer's disease (992)
Antibody-drug conjugate (ADC) (306)
Approvals (10450)
Artificial intelligence (353)
ASCO (160)
Autoimmune disease (233)
Automation (32)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6958)
BIO (36)
Biologics (28)
BIOSECURE Act (1)
Biosimilars (123)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (8)
Bladder cancer (141)
Brain cancer (34)
Breast cancer (528)
Cancer (3897)
Cardiovascular disease (235)
Career advice (247)
Career pathing (2)
CAR-T (184)
CDC (1)
CDMO (27)
Celiac Disease (3)
Cell therapy (503)
Cervical cancer (36)
Clinical research (48306)
Collaboration (1333)
Commercialization (20)
Compensation (1597)
Complete response letters (36)
COVID-19 (770)
CRISPR (66)
C-suite (837)
Cystic fibrosis (88)
Data (6175)
Denatured (4)
Depression (108)
Dermatology (93)
Diabetes (377)
Diagnostics (4251)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (168)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (174)
Earnings (73848)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88537)
Executive appointments (729)
Eye disease (3)
FDA (12622)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (989)
Gene editing (129)
Generative AI (13)
Gene therapy (345)
GLP-1 (306)
Government (950)
Grass and pollen (2)
Guidances (281)
Healthcare (9386)
Hematology (94)
HIV (55)
Huntington's disease (25)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (73)
Immunology and inflammation (111)
Immuno-oncology (65)
Indications (175)
Infectious disease (970)
Inflammatory bowel disease (136)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (269)
Interviews (43)
IPO (12399)
IRA (2)
Job creations (1970)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (63)
Labor market (1)
Layoffs (60)
Legal (5195)
Licensing (41)
Liver cancer (47)
Longevity (22)
Lung cancer (561)
Lung diease (8)
Lymphoma (265)
Machine learning (29)
Management (3)
Manufacturing (606)
Marketing (14)
MASH (120)
Medical affairs (2)
Medical device (8713)
Medtech (8887)
Mergers & acquisitions (14442)
Metabolic disorders (757)
mRNA (70)
Multiple sclerosis (110)
Multispecific (2)
NASH (4)
Netherlands (1)
Neurodegenerative disease (236)
Neuropsychiatric disorders (40)
Neuroscience (1917)
Neurotech (1)
NextGen: Class of 2026 (3152)
Non-profit (844)
Obesity (237)
Opinion (10)
Ovarian cancer (175)
Pain (184)
Pancreatic cancer (223)
Parkinson's disease (215)
Partnered (12)
Patents (521)
Patient advocacy (2)
Patient recruitment (546)
Patient selection (31)
Peanut (33)
People (41492)
Peptides (11)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15591)
Phase 2 (21583)
Phase 3 (14563)
Pipeline (8182)
Policy (18)
Postmarket research (1570)
Preclinical (6578)
Press Release (34)
Prostate cancer (201)
Psychedelics (10)
Radiopharmaceuticals (202)
Rare diseases (616)
Real estate (3025)
Recruiting (6)
Regenerative medicine (11)
Regulatory (15146)
Reports (23)
Research institute (590)
Resumes & cover letters (46)
Rett syndrome (45)
RNA editing (8)
RSV (49)
Schizophrenia (108)
Series A (173)
Series B (126)
Service/supplier (5)
Sickle cell disease (64)
Spinal muscular atrophy (92)
Sponsored (5)
Startups (2024)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (54)
Tariffs (1)
Vaccines (344)
Venture capital (17)
Weight loss (76)
Wet AMD (1)
Women's health (95)
Date
Today (93)
Last 7 days (356)
Last 30 days (1498)
Last 365 days (19230)
2026 (14983)
2025 (19253)
2024 (22989)
2023 (26559)
2022 (34606)
2021 (37183)
2020 (33498)
2019 (23275)
2018 (17481)
2017 (18791)
2016 (17928)
2015 (24275)
2014 (21684)
2013 (18137)
2012 (20228)
2011 (20445)
2010 (20338)
Location
Africa (231)
Alabama (80)
Alaska (2)
Arizona (317)
Arkansas (12)
Asia (18023)
Australia (2116)
California (12718)
Canada (3327)
China (564)
Colorado (517)
Connecticut (444)
Delaware (220)
Europe (24888)
Florida (1916)
Georgia (402)
Hawaii (3)
Idaho (46)
Illinois (791)
India (57)
Indiana (330)
Iowa (17)
Japan (444)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1257)
Massachusetts (8317)
Michigan (319)
Minnesota (588)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (129)
New Hampshire (60)
New Jersey (2800)
New Mexico (12)
New York (2983)
North Carolina (1347)
North Dakota (4)
Northern California (6426)
Ohio (301)
Oklahoma (14)
Oregon (16)
Pennsylvania (2364)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (80)
South Dakota (1)
Southern California (5299)
Tennessee (128)
Texas (2098)
United States (41249)
Utah (385)
Vermont (1)
Virginia (162)
Washington D.C. (39)
Washington State (979)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
487,571 Results for "ibio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
iBio Accelerates Transformation to AI-Powered Biotech
BRYAN, Texas and SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) an AI-driven innovator of precision antibody immunotherapies, announces it is seeking to divest its contract development and manufacturing organization
November 10, 2022
·
7 min read
iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline
SAN DIEGO and BRYAN, Texas, Sept. 21, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System
November 10, 2022
·
7 min read
iBio to Participate in the H.C. Wainwright Global Investment Conference
BRYAN, Texas, May 18, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming® Manufacturing System,
November 10, 2022
·
1 min read
iBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update
BRYAN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System,
November 10, 2022
·
15 min read
iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update
BRYAN, Texas and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the
November 10, 2022
·
10 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Business
RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.
RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements directed towards the research, development, and commercialization of epitope-targeted antibody therapeutics.
August 25, 2021
·
4 min read
Pharm Country
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform.
January 30, 2024
·
2 min read
BioMidwest
iBIO Launches Transform Illinois Program
iBIO, the Illinois Biotechnology Innovation Organization, announced the launch of Transform Illinois, http://ibio.org, its innovative new program to enhance pandemic preparedness and recovery, erase health equity barriers and continue to nurture the state’s life sciences community.
July 30, 2020
·
5 min read
BioMidwest
iBIO Releases Four-week Totals for the iBIO COVID-19 PPE Response Fund
iBIO, the Illinois Biotechnology Innovation Organization, today announced a summary of the iBIO COVID-19 PPE Response Fund’s impact since its March 23 launch.
April 23, 2020
·
3 min read
1 of 48,758
Next
